Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Spire To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Spire between March 6, 2024 and August 14, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi […]
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Methode Electronics To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Methode Electronics between June 23, 2022 and March 6, 2024 and would like to discuss your legal rights, call Faruqi
NEW YORK, NY / ACCESSWIRE / September 23, 2024 / If you suffered a loss on your Vicor Corporation (NASDAQ:VICR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/vicor-corporation-lawsuit-submission-form?prid=104551&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)
NEW YORK, NY / ACCESSWIRE / September 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Aviat Networks, Inc. ("Aviat Networks, Inc.") (NASDAQ:AVNW) concerning possible violations of federal securities laws. Aviat announced on September 11, 2024, its inability to file the Annual Report on Form 10-K for the fiscal
NEW YORK, NY / ACCESSWIRE / September 23, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Arbor Realty Trust, Inc. ("Arbor" or the "Company") (NYSE:ABR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
EXTON, PA, Sept. 23, 2024 (GLOBE NEWSWIRE) — Spherix Global Insights compiled data from their RealTime Dynamix(TM) services in Crohn’s Disease, Rheumatoid Arthritis, and Psoriasis, fielded in late April 2024 (n=104 gastroenterologists, 103 rheumatologists, and 106 dermatologists), to provide an updated perspective on adalimumab biosimilar penetration and prescriber sentiments. This data was further enhanced by
WALTHAM, Mass., Sept. 23, 2024 (GLOBE NEWSWIRE) — In today’s rapidly changing labor market, staying ahead of the curve requires insightful analysis based on real-time compensation data. With this growing need for trusted data and intuitive software, Salary.com will highlight its award-winning solutions, including its latest offering, SalaryIQ(TM), during this week’s HR Technology Conference &
NEW YORK, NY / ACCESSWIRE / September 23, 2024 / If you suffered a loss on your XPEL, Inc. (NASDAQ:XPEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/xpel-inc-lawsuit-submission-form?prid=104561&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)
NEW YORK, NY / ACCESSWIRE / September 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Flux Power Holdings, Inc. ("Flux Power Holdings, Inc.") (NASDAQ:FLUX) concerning possible violations of federal securities laws. On September 5, 2024, in a filing with the U.S. Securities and Exchange Commission ("SEC"), Flux disclosed
NEW YORK, NY / ACCESSWIRE / September 23, 2024 / If you suffered a loss on your Ardelyx, Inc. (NASDAQ:ARDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ardelyx-lawsuit-submission-form?prid=104559&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)